Source:http://linkedlifedata.com/resource/pubmed/id/19236792
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-2-24
|
pubmed:abstractText |
Multiple myeloma (MM) is a common disease with various prognoses. Accurate prognosis judgement is of great significance for clinical treatment. In this review, summarized most recent progress on evaluating index of this disease from aspects of age, tumor load, cytogenetic disturbance, serological analysis, CD antigens, non-invasive physical examinations, staging system and so on were summarized in order to provide new information on treatment and prognosis evaluation of this disease.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1009-2137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-60
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
[Advance of study on evaluating index for multiple myeloma prognosis -- review].
|
pubmed:affiliation |
Department of Hematology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|